Literature DB >> 21909718

Quercetin regulates organic ion transporter and uromodulin expression and improves renal function in hyperuricemic mice.

Qing-Hua Hu1, Xian Zhang, Xing Wang, Rui-Qing Jiao, Ling-Dong Kong.   

Abstract

BACKGROUND: Renal organic ion transporters and uromodulin (UMOD) play the important roles in renal urate excretion and function. Hyperuricemia is considered as a risk factor for the development of renal dysfunction. The flavonoid quercetin in diets exerts the hypouricemic and nephroprotective effects. PURPOSES: To evaluate the effects of quercetin on renal organic ion transporters and UMOD in hyperuricemic mice.
METHODS: Kun-Ming mice were divided into normal and hyperuricemic groups receiving water, 25, 50 and 100 mg/kg quercetin, 5 mg/kg allopurinol, respectively. Hyperuricemic mice were orally gavaged with 250 mg/kg oxonate daily for 1 week. Quercetin and allopurinol were orally gavaged on the day when oxonate or water was given 1 h later. After 1 week, serum uric acid, creatinine and blood urea nitrogen concentrations, excretion of urate and creatinine, and fractional excretion of uric acid were measured. The mRNA and protein levels of renal urate transporter 1 (mURAT1), glucose transporter 9 (mGLUT9), organic anion transporter 1 (mOAT1) and organic cation/carnitine transporters (mOCT1, mOCT2, mOCTN1 and mOCTN2) in mice were analyzed. Simultaneously, UMOD levels in serum, urine and kidney, as well as renal UMOD mRNA expression were detected.
RESULTS: Quercetin significantly restored oxonate-induced abnormalities of these biochemical indexes compared with normal vehicle group. Furthermore, it remarkably prevented expression changes of renal organic ion transporters and UMOD, and UMOD level alteration in hyperuricemic mice.
CONCLUSIONS: These results suggest that quercetin has the uricosuric and nephroprotective actions mediated by regulating the expression levels of renal organic ion transporters and UMOD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21909718     DOI: 10.1007/s00394-011-0243-y

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  56 in total

1.  Treatment of interstitial cystitis with a quercetin supplement.

Authors:  F Katske; D A Shoskes; M Sender; R Poliakin; K Gagliano; J Rajfer
Journal:  Tech Urol       Date:  2001-03

Review 2.  Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles.

Authors:  Ahsan N Rizwan; Gerhard Burckhardt
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

Review 3.  Safety of quercetin for clinical application (Review).

Authors:  Toshihiro Okamoto
Journal:  Int J Mol Med       Date:  2005-08       Impact factor: 4.101

4.  Effects of dietary flavonoids on the transport of cimetidine via P-glycoprotein and cationic transporters in Caco-2 and LLC-PK1 cell models.

Authors:  J-S Taur; R Rodriguez-Proteau
Journal:  Xenobiotica       Date:  2008-12       Impact factor: 1.908

5.  Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study.

Authors:  Sarah Egert; Anja Bosy-Westphal; Jasmin Seiberl; Claudia Kürbitz; Uta Settler; Sandra Plachta-Danielzik; Anika E Wagner; Jan Frank; Jürgen Schrezenmeir; Gerald Rimbach; Siegfried Wolffram; Manfred J Müller
Journal:  Br J Nutr       Date:  2009-04-30       Impact factor: 3.718

6.  Hypouricemic action of selected flavonoids in mice: structure-activity relationships.

Authors:  Shi-Fu Mo; Feng Zhou; Yao-Zhong Lv; Qing-Hua Hu; Dong-Mei Zhang; Ling-Dong Kong
Journal:  Biol Pharm Bull       Date:  2007-08       Impact factor: 2.233

7.  Mouse GLUT9: evidences for a urate uniporter.

Authors:  Stéphanie Bibert; Solange Kharoubi Hess; Dmitri Firsov; Bernard Thorens; Käthi Geering; Jean-Daniel Horisberger; Olivier Bonny
Journal:  Am J Physiol Renal Physiol       Date:  2009-07-08

Review 8.  A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties.

Authors:  M Harwood; B Danielewska-Nikiel; J F Borzelleca; G W Flamm; G M Williams; T C Lines
Journal:  Food Chem Toxicol       Date:  2007-06-07       Impact factor: 6.023

Review 9.  Antihypertensive effects of the flavonoid quercetin.

Authors:  Francisco Perez-Vizcaino; Juan Duarte; Rosario Jimenez; Celestino Santos-Buelga; Antonio Osuna
Journal:  Pharmacol Rep       Date:  2009 Jan-Feb       Impact factor: 3.024

10.  Onion peel extracts ameliorate hyperglycemia and insulin resistance in high fat diet/streptozotocin-induced diabetic rats.

Authors:  Ji Young Jung; Yeni Lim; Min Sun Moon; Ji Yeon Kim; Oran Kwon
Journal:  Nutr Metab (Lond)       Date:  2011-03-28       Impact factor: 4.169

View more
  10 in total

Review 1.  Antioxidants from black and green tea: from dietary modulation of oxidative stress to pharmacological mechanisms.

Authors:  Ilaria Peluso; Mauro Serafini
Journal:  Br J Pharmacol       Date:  2016-11-12       Impact factor: 8.739

2.  Integrated Molecular Docking with Network Pharmacology to Reveal the Molecular Mechanism of Simiao Powder in the Treatment of Acute Gouty Arthritis.

Authors:  Yihua Fan; Wei Liu; Yue Jin; Xu Hou; Xuewu Zhang; Hudan Pan; Hang Lu; Xiaojing Guo
Journal:  Evid Based Complement Alternat Med       Date:  2021-04-27       Impact factor: 2.629

3.  Quercetin Inhibits Fibroblast Activation and Kidney Fibrosis Involving the Suppression of Mammalian Target of Rapamycin and β-catenin Signaling.

Authors:  Jiafa Ren; Jianzhong Li; Xin Liu; Ye Feng; Yuan Gui; Junwei Yang; Weichun He; Chunsun Dai
Journal:  Sci Rep       Date:  2016-04-07       Impact factor: 4.379

Review 4.  Natural Products Improving Hyperuricemia with Hepatorenal Dual Effects.

Authors:  Shijun Hao; Chunlei Zhang; Haiyan Song
Journal:  Evid Based Complement Alternat Med       Date:  2016-10-25       Impact factor: 2.629

Review 5.  Dietary Antioxidant Supplements and Uric Acid in Chronic Kidney Disease: A Review.

Authors:  Stefanos Roumeliotis; Athanasios Roumeliotis; Evangelia Dounousi; Theodoros Eleftheriadis; Vassilios Liakopoulos
Journal:  Nutrients       Date:  2019-08-15       Impact factor: 5.717

6.  Molecular mechanistic insight into the anti-hyperuricemic effect of Eucommia ulmoides in mice and rats.

Authors:  Cong Fang; Lanying Chen; Mingzhen He; Yingying Luo; Mengjing Zhou; Ni Zhang; Jinfeng Yuan; Huiling Wang; Yongyan Xie
Journal:  Pharm Biol       Date:  2019-12       Impact factor: 3.503

7.  Preventive Effects of Fucoidan and Fucoxanthin on Hyperuricemic Rats Induced by Potassium Oxonate.

Authors:  Yung-Tsung Chau; Hsin-Yuan Chen; Po-Han Lin; Shih-Min Hsia
Journal:  Mar Drugs       Date:  2019-06-10       Impact factor: 5.118

Review 8.  A review on benefits of quercetin in hyperuricemia and gouty arthritis.

Authors:  Thanutchaporn Nutmakul
Journal:  Saudi Pharm J       Date:  2022-04-30       Impact factor: 4.562

9.  Renal oxidative stress induced by long-term hyperuricemia alters mitochondrial function and maintains systemic hypertension.

Authors:  Magdalena Cristóbal-García; Fernando E García-Arroyo; Edilia Tapia; Horacio Osorio; Abraham S Arellano-Buendía; Magdalena Madero; Bernardo Rodríguez-Iturbe; José Pedraza-Chaverrí; Francisco Correa; Cecilia Zazueta; Richard J Johnson; Laura-Gabriela Sánchez Lozada
Journal:  Oxid Med Cell Longev       Date:  2015-03-31       Impact factor: 6.543

10.  Impact of Lesinurad and allopurinol on experimental Hyperuricemia in mice: biochemical, molecular and Immunohistochemical study.

Authors:  Youssef Saeed Alghamdi; Mohamed Mohamed Soliman; Mohamed Abdo Nassan
Journal:  BMC Pharmacol Toxicol       Date:  2020-02-10       Impact factor: 2.483

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.